A global team of researchers has discovered a new biomarker that could be used to detect Alzheimer’s disease decades before symptoms emerge.
Alzheimer’s disease affects more than 340,000 Australians and it is well documented that early diagnosis is the best hope for effective treatment.
The study, published in Nature Medicine, examined the pattern of ‘tau’ protein build-up in the brains of 370 people with an inherited form of Alzheimer’s disease.
Tau and another protein called beta-amyloid are known to be closely associated with the development of Alzheimer’s disease, a form of brain degeneration.
The researchers, including Professor Ralph Martins from Edith Cowan University (ECU),…
